West Pharmaceutical stock steadies after Q2 beat and raised outlook
Published on 08/26/2026 at 18:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
West Pharmaceutical Services, Inc. (NYSE:WST) traded at $348.48 on August 26, 2026, after a $4.84 decline, while market value stood at $24.525 billion. The stock also moved after second-quarter results on July 23, 2026, when revenue reached $872.3 million and adjusted EPS came in at $2.37.
Q2 numbers stay in view
Revenue topped the $839.98 million consensus by $32.32 million, and EPS beat the $2.08 estimate by $0.29. The same report showed revenue up 13.8% from a year earlier, when quarterly revenue was $1.84 billion? No, the prior-year EPS figure was $1.84, so the clear comparison is the 13.8% revenue gain and the $0.29 EPS beat.
Guidance now points to Q3 2026 EPS of $2.14 to $2.24 and FY 2026 EPS of $8.85 to $9.05, while analysts on August 26, 2026, were looking for $8.93 for the year. That gap leaves the market focused on whether West Pharmaceutical can keep earnings above the current consensus pace.
Consensus and valuation
Market data also places the stock at a market cap of $24.56 billion, a trailing P/E of 44.68, and a dividend yield of 0.3%. The message for investors is simple: the operating print was solid, but the valuation still asks for sustained execution.
West Pharmaceutical products
West Pharmaceutical's core business centers on packaging and delivery systems used with injectable medicines, including containment and elastomer components that support drug stability and administration. That product mix matters because Q2 sales strength and the higher FY 2026 EPS guide both point to demand that is still supporting the company's core platform.
Shares at a premium
West Pharmaceutical Services stock closed at $348.48 on August 26, 2026, with after-hours trading at $349.00. The market cap of $24.525 billion and the Q2 EPS beat of $0.29 keep the shares priced for steady follow-through.
Fact box
Company: West Pharmaceutical Services, Inc.
ISIN: US9523901012
Ticker: WST
Exchange: NYSE
Price (as of August 26, 2026, 4:02 p.m. EDT): $348.48 USD
Market cap: $24.525 billion (as of August 26, 2026)
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: S&P 500
